1. Home
  2. CHGA vs ARTL Comparison

CHGA vs ARTL Comparison

Compare CHGA & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Change Agents Corporation Common Stock

CHGA

Change Agents Corporation Common Stock

N/A

Current Price

$2.35

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$5.99

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHGA
ARTL
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.2M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
CHGA
ARTL
Price
$2.35
$5.99
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
6.5M
219.1K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
33.18
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.52
52 Week High
$3.02
$19.91

Technical Indicators

Market Signals
Indicator
CHGA
ARTL
Relative Strength Index (RSI) 82.70 92.20
Support Level $0.16 $1.01
Resistance Level $3.02 $19.91
Average True Range (ATR) 0.12 0.28
MACD 0.28 0.71
Stochastic Oscillator 78.95 94.67

Price Performance

Historical Comparison
CHGA
ARTL

About CHGA Change Agents Corporation Common Stock

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: